| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9312766 | Urology | 2005 | 4 Pages |
Abstract
A significant association between the pretreatment risk group and posttreatment PSADT was demonstrated. Use of this selection criterion at diagnosis for more aggressive treatment appears warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Clair Beard, Ming-Hui Chen, Kerri Cote, Marian Loffredo, Andrew Renshaw, Mark Hurwitz, Anthony V. D'Amico,